Julian R. F. Walters, Ali M. Tasleem, Omer S. Omer, W

Slides:



Advertisements
Similar presentations
Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea  Banny S. Wong, Michael Camilleri, Paula Carlson, Sanna McKinzie,
Advertisements

Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome–Diarrhea Without Bile Acid Malabsorption  Cédric Peleman,
Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis  Konstantinos.
The Role of Psychosocial Care in Adapting to Health Care Reform
Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Methods for Diagnosis of Bile Acid Malabsorption in Clinical Practice
Bile Acid Synthesis in Humans Has a Rapid Diurnal Variation That Is Asynchronous With Cholesterol Synthesis  Cecilia Gälman, Bo Angelin, Mats Rudling 
The FXR-FGF19 Gut–Liver Axis as a Novel “Hepatostat”
Volume 146, Issue 4, Pages (April 2014)
Volume 146, Issue 4, Pages (April 2014)
Homing in on bile acid physiology
Pichamol Jirapinyo, Christopher C. Thompson 
Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea  Banny S. Wong, Michael Camilleri, Paula Carlson, Sanna McKinzie,
Coordinating Care in Patients With Cirrhosis
Katsunori Matsueda, Tatsuya Toyokawa 
David L. McCollum, J. Martin Rodriguez 
Colonic Amyloidosis Clinical Gastroenterology and Hepatology
Lucio Gullo  Clinical Gastroenterology and Hepatology 
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study  Harry Wu, Geoffrey C. Nguyen  Clinical.
Prevalence and Mechanisms of Malnutrition in Patients With Advanced Liver Disease, and Nutrition Management Strategies  Kally Cheung, Samuel S. Lee, Maitreyi.
Amani Al-Khaifi, Mats Rudling, Bo Angelin  Gastroenterology 
Mucosal Healing in Patients With Celiac Disease and Outcomes of Pregnancy: A Nationwide Population-Based Study  Benjamin Lebwohl, Olof Stephansson, Peter.
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Targeting the FXR Nuclear Receptor to Treat Liver Disease
Targeting the gut-liver axis in liver disease
Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD 
Markers of Eosinophilic Inflammation for Diagnosis of Eosinophilic Esophagitis and Proton Pump Inhibitor–Responsive Esophageal Eosinophilia: A Prospective.
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease  Elana A. Maser, Renata Villela,
Carbohydrate Maldigestion and Malabsorption
Activity-Based Costing and Management in a Hospital-Based GI Unit
Issue Highlights Clinical Gastroenterology and Hepatology
DCo(H2)ding the Metabolic Functions of SIRT1 in the Intestine
Traveling Internationally: Avoiding and Treating Travelers' Diarrhea
Features and Outcomes of Patients With Ischemia Isolated to the Right Side of the Colon When Accompanied or Followed by Acute Mesenteric Ischemia  Paul.
Abnormal Liver Tests and Fatty Liver on Ultrasound
Another Shp on the Horizon for Bile Acids
New Models of Gastroenterology Practice
Ramesh Kumar, Masiullah, Pintu Kumar Singh 
Stephen J. Rulyak, David A. Lieberman, Edward H. Wagner, Margaret T
Issue Highlights Clinical Gastroenterology and Hepatology
Chronic Diarrhea Due to Excessive Bile Acid Synthesis and Not Defective Ileal Transport: A New Syndrome of Defective Fibroblast Growth Factor 19 Release 
Volume 17, Issue 6, Pages (June 2013)
Volume 7, Issue 1, Pages (April 2014)
Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis  Konstantinos.
Annual Burden and Costs of Hospitalization for High-Need, High-Cost Patients With Chronic Gastrointestinal and Liver Diseases  Nghia H. Nguyen, Rohan.
Amnon Sonnenberg  Clinical Gastroenterology and Hepatology 
Cholelithiasis in a Patient With History of Cholecystectomy
Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysis  Neeraj Narula, Abdul-Aziz Alshahrani,
Issue Highlights Clinical Gastroenterology and Hepatology
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Issue Highlights Clinical Gastroenterology and Hepatology
Cyrus Piraka, Raj J. Shah, Nida S. Awadallah, Daniel A. Langer, Yang K
Effects of Chenodeoxycholate and a Bile Acid Sequestrant, Colesevelam, on Intestinal Transit and Bowel Function  Suwebatu T. Odunsi–Shiyanbade, Michael.
Thrombocytopenia With Abnormal Liver Function Tests
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Genetics of Hepatobiliary Diseases
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Effects of Chenodeoxycholate and a Bile Acid Sequestrant, Colesevelam, on Intestinal Transit and Bowel Function  Suwebatu T. Odunsi–Shiyanbade, Michael.
Homing in on bile acid physiology
Black and White Liver Clinical Gastroenterology and Hepatology
Issue Highlights Clinical Gastroenterology and Hepatology
Sanjay K. Murthy, E. Jenny Heathcote, Geoffrey C. Nguyen 
The Role of Psychosocial Care in Adapting to Health Care Reform
Volume 157, Issue 2, Pages (August 2019)
Karanprit Singh, Prateek Chapalamadugu, Peter Malet 
Choosing Wisely and the Perceived Drivers of Endoscopy Use
Presentation transcript:

A New Mechanism for Bile Acid Diarrhea: Defective Feedback Inhibition of Bile Acid Biosynthesis  Julian R.F. Walters, Ali M. Tasleem, Omer S. Omer, W. Gordon Brydon, Tracy Dew, Carel W. le Roux  Clinical Gastroenterology and Hepatology  Volume 7, Issue 11, Pages 1189-1194 (November 2009) DOI: 10.1016/j.cgh.2009.04.024 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 (A) Fasting serum values in patients and control subjects for C4 and (B) FGF19. Individual values and box and whisker plots with medians, quartiles (boxes), and 5 and 95 percentiles (lines) are shown. In the patient group, solid circles indicate patients who had low SeHCAT tests and open circles those without SeHCAT tests. Clinical Gastroenterology and Hepatology 2009 7, 1189-1194DOI: (10.1016/j.cgh.2009.04.024) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Inverse relationship of fasting values of serum FGF19 and C4 in patients (solid circles) and control subjects (open circles). Clinical Gastroenterology and Hepatology 2009 7, 1189-1194DOI: (10.1016/j.cgh.2009.04.024) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Changes during the day in 6 patients in serum values of (A) C4 and (B) FGF19. Three patients had undergone cholecystectomy (open symbols) and 3 had not (solid symbols). Two patients (shown by the solid square and the solid triangle symbols) had no increase in FGF19 during the day. The arrows show where breakfast and lunch were eaten after taking the 9:00 and 12:00 samples. Clinical Gastroenterology and Hepatology 2009 7, 1189-1194DOI: (10.1016/j.cgh.2009.04.024) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 Changes in the enterohepatic circulation of bile acids that are proposed to cause primary bile acid malabsorption diarrhea. (A) Normal and (B) primary BAM. The width of the lines and arrows indicate the amounts of fibroblast growth factor 19 (FGF19) (black), stool (dark gray), or bile acid (BA) (mid-gray). Synthesis of BA occurs in the liver from cholesterol (Chol) by the action of cholesterol 7α hydroxylase (CYP7A1), forming C4 and then BA. Secretion of BA into the intestine is shown schematically, and the dotted line inset demonstrates absorption in the ileum, where BAs act on farnesoid X receptor (FXR) to stimulate FGF19 production. FGF19 enters the portal venous circulation and inhibits CYP7A1 action. In (B), less FGF19 is produced in the ileum, so CYP7A1 action is greater, producing more BA. Normal BA absorption occurs in the ileum, but more BAs are left unabsorbed and enter the colon, where increased secretion occurs, causing increased stool volume. Clinical Gastroenterology and Hepatology 2009 7, 1189-1194DOI: (10.1016/j.cgh.2009.04.024) Copyright © 2009 AGA Institute Terms and Conditions